SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-250285
Filing Date
2022-09-23
Accepted
2022-09-23 17:27:37
Documents
13
Period of Report
2022-09-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d320308d8k.htm   iXBRL 8-K 26084
2 EX-10.1 d320308dex101.htm EX-10.1 74049
  Complete submission text file 0001193125-22-250285.txt   241339

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA logc-20220921.xsd EX-101.SCH 2860
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE logc-20220921_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE logc-20220921_pre.xml EX-101.PRE 11710
7 EXTRACTED XBRL INSTANCE DOCUMENT d320308d8k_htm.xml XML 3471
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Filer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38707 | Film No.: 221263106
SIC: 2836 Biological Products, (No Diagnostic Substances)